Element Biosciences

Element Biosciences Opening the world of biology to new possibilities. To learn more about Element, please visit www.elementbiosciences.com.

Element Biosciences is a multi-disciplinary life science company focused on developing disruptive DNA sequencing and other omics technology for research markets. Through innovating every fundamental element of a sequencing system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries and broaden the use of genomic research.

☀️ Sunshine, good food, and even better company — Element's annual summer picnic brought our team and their families tog...
08/10/2026

☀️ Sunshine, good food, and even better company — Element's annual summer picnic brought our team and their families together last week for an afternoon of celebrating our community.

🌴 Leilani's Cafe brought the Hawaiian flavors, and there were games for kids and adults to keep the fun going all afternoon. Great food, great company, and a well-earned break from the day-to-day.

Grateful to everyone who came out and made it a day to remember. See you next summer! 😎

SNP arrays, targeted sequencing, or low-pass whole-genome sequencing with imputation? Genotyping method selection for li...
08/06/2026

SNP arrays, targeted sequencing, or low-pass whole-genome sequencing with imputation? Genotyping method selection for livestock breeding isn't settled, and each approach carries a real tradeoff in cost, speed, and accuracy. 🐄🧬

Justin Kos breaks down how each method works, where it holds up, where it doesn’t, and digs into what happens at the small fraction of sites where a microarray and a sequencing-based method disagree.

Read the full breakdown: https://bit.ly/4z5lzUI.

How do you benchmark sequencing accuracy without the benchmark itself being biased? 🤔 Reference genomes like GRCh38 were...
08/05/2026

How do you benchmark sequencing accuracy without the benchmark itself being biased? 🤔 Reference genomes like GRCh38 were built predominantly from short-read SBS sequencing data. That means errors baked into the reference are invisible, and real biology can get mislabeled as "sequencer error”.

A new preprint from the Northwest Genomics Center and collaborators across NIH's SMaHT Network addressed this limitation by developing donor-specific assemblies (DSAs), diploid reference genomes built entirely from long-read + Hi-C data, with zero short-read influence on base calls. That gave them a technology-agnostic yardstick to compare the accuracy of nine short-read platforms.

What they found:

📊 After standard quality filtering, the Element AVITI™ showed significantly lower error rates, particularly with UltraQ™ chemistry which had the lowest error of any platform tested.

🔍 In low-complexity regions, where many high-value variants live, AVITI held the lowest SNV and indel error rate.

The full breakdown covers the methodology, the figures, and the comparison results. Read it: https://bit.ly/4xlbT6H.

We're in Houston this week for the Cancer Genomics Consortium Annual Meeting! 🧬 Targeted sequencing is evolving fast, an...
08/04/2026

We're in Houston this week for the Cancer Genomics Consortium Annual Meeting!

🧬 Targeted sequencing is evolving fast, and we're excited to share how Element is pushing it further with Trinity™ on-flow cell hybrid capture on the AVITI24™ platform — bringing more precision and flexibility to your workflow.

If you're at the conference, stop by our booth. We'd love to walk you through what makes this approach different and hear what you're working on. 🔬

⏱️ Turnaround time can be a bottleneck in clinical research, especially when doing targeted sequencing.Our getting start...
08/03/2026

⏱️ Turnaround time can be a bottleneck in clinical research, especially when doing targeted sequencing.

Our getting started guide covers how 🧬 AVITI24™ and Trinity™ help labs complete target enrichment workflows in as little as one day, without sacrificing the data quality their research demands.

Download the guide: https://bit.ly/4dC6EsX.

That's a wrap on ADLM! 🧬 Thanks to everyone who stopped by our booth to see the AVITI24™ in person and learn how we're p...
07/31/2026

That's a wrap on ADLM! 🧬 Thanks to everyone who stopped by our booth to see the AVITI24™ in person and learn how we're pairing AVITI24 sequencing with SOPHiA DDM analysis for a true end-to-end clinical research workflow.

Great conversations with SOPHiA Genetics and the community — see you at the next one!

07/30/2026

Sometimes one sequencing run is all it takes to change a lab's trajectory.

Dr. Peter Lansdorp, BC Cancer Institute, shares how their lab first encountered AVITI™ sequencing through the UC Davis DNA Core facility, where their Strand-seq libraries were processed. The results made the case on their own: better data at a lower price. As demand for Strand-seq work grew in their lab, that data helped them secure funding for an AVITI instrument of their own. 🧬

Being an early adopter paid off — lower costs have given the team more freedom to pursue higher-risk, higher-reward experiments.

Explore more of their story: https://bit.ly/43jye7N.

Sequencing data quality can be complicated by PCR-based amplification. Errors compound with copies of a copy, homopolyme...
07/29/2026

Sequencing data quality can be complicated by PCR-based amplification. Errors compound with copies of a copy, homopolymers get messier, and fragment size runs into limitations. 🎯

ABC™ sequencing skips PCR. Rolling circle amplification copies the template and rolls it into a dense polony, without compounding errors. Pair that with an unlabeled terminator (no fluorescence carryover, no DNA scarring from dye cleavage), and you get a chemistry designed to limit noise buildup cycle after cycle. 🔄

Get the details in our infographic: https://bit.ly/4gBE4JA.

What a week at AACR D3 in Boston! 🧬 It was great connecting with so many people at the intersection of drug discovery an...
07/28/2026

What a week at AACR D3 in Boston! 🧬 It was great connecting with so many people at the intersection of drug discovery and multimodal research — a space where the AVITI24™ is right at home. Thanks to everyone who stopped by to talk about how to see more biology behind every assay. Looking forward to continuing those conversations.

We are proud to share that Element was named among San Diego's 100 Business Impact Award honorees by the San Diego Regio...
07/27/2026

We are proud to share that Element was named among San Diego's 100 Business Impact Award honorees by the San Diego Regional EDC and JP Morgan Chase!

Thank you to the San Diego Regional EDC and JP Morgan Chase for hosting last week's Business Impact Awards and for celebrating the companies creating real economic impact across our region.

At Element, we're honored to be part of San Diego's thriving life science community, and the drive to enable ever greater access to vital scientific innovation for researchers everywhere.

Congratulations to all the honorees!

Address

10055 Barnes Canyon Road, Suite 100
San Diego, CA
92121

Alerts

Be the first to know and let us send you an email when Element Biosciences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Element Biosciences:

Shortcuts

Featured

Share